Phospho-p62 Dok (Tyr362) Antibody - #AF3478
| Product: | Phospho-p62 Dok (Tyr362) Antibody |
| Catalog: | AF3478 |
| Description: | Rabbit polyclonal antibody to Phospho-p62 Dok (Tyr362) |
| Application: | WB IF/ICC |
| Reactivity: | Human, Mouse, Rat |
| Prediction: | Pig, Bovine, Horse, Sheep, Rabbit, Dog |
| Mol.Wt.: | 62kDa; 52kD(Calculated). |
| Uniprot: | Q99704 |
| RRID: | AB_2834916 |
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF3478, RRID:AB_2834916.
Fold/Unfold
Docking protein 1 62kD; Docking protein 1; DOK 1; DOK1; DOK1_HUMAN; Downstream of tyrosine kinase 1; p62(dok); P62DOK; pp62;
Immunogens
Expressed in pancreas, heart, leukocyte and spleen. Expressed in both resting and activated peripheral blood T-cells. Expressed in breast cancer.
- Q99704 DOK1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDGAVMEGPLFLQSQRFGTKRWRKTWAVLYPASPHGVARLEFFDHKGSSSGGGRGSSRRLDCKVIRLAECVSVAPVTVETPPEPGATAFRLDTAQRSHLLAADAPSSAAWVQTLCRNAFPKGSWTLAPTDNPPKLSALEMLENSLYSPTWEGSQFWVTVQRTEAAERCGLHGSYVLRVEAERLTLLTVGAQSQILEPLLSWPYTLLRRYGRDKVMFSFEAGRRCPSGPGTFTFQTAQGNDIFQAVETAIHRQKAQGKAGQGHDVLRADSHEGEVAEGKLPSPPGPQELLDSPPALYAEPLDSLRIAPCPSQDSLYSDPLDSTSAQAGEGVQRKKPLYWDLYEHAQQQLLKAKLTDPKEDPIYDEPEGLAPVPPQGLYDLPREPKDAWWCQARVKEEGYELPYNPATDDYAVPPPRSTKPLLAPKPQGPAFPEPGTATGSGIKSHNSALYSQVQKSGASGSWDCGLSRVGTDKTGVKSEGST
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q99704 As Substrate
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| M1 | Acetylation | Uniprot | |
| Y30 | Phosphorylation | Uniprot | |
| S33 | Phosphorylation | Uniprot | |
| R39 | Methylation | Uniprot | |
| K46 | Ubiquitination | Uniprot | |
| S48 | Phosphorylation | Uniprot | |
| T93 | Phosphorylation | Uniprot | |
| K121 | Ubiquitination | Uniprot | |
| S123 | Phosphorylation | Uniprot | |
| T125 | Phosphorylation | Uniprot | |
| Y146 | Phosphorylation | Uniprot | |
| Y203 | Phosphorylation | Uniprot | |
| S217 | Phosphorylation | Uniprot | |
| K257 | Ubiquitination | Uniprot | |
| S269 | Phosphorylation | Uniprot | |
| S281 | Phosphorylation | Uniprot | |
| S291 | Phosphorylation | Uniprot | |
| Y296 | Phosphorylation | Uniprot | |
| C308 | S-Nitrosylation | Uniprot | |
| S310 | Phosphorylation | Uniprot | |
| S313 | Phosphorylation | Uniprot | |
| Y315 | Phosphorylation | Uniprot | |
| S316 | Phosphorylation | Uniprot | |
| Y337 | Phosphorylation | Uniprot | |
| Y341 | Phosphorylation | Uniprot | |
| T354 | Phosphorylation | Uniprot | |
| Y362 | Phosphorylation | P00519 (ABL1) , P06213 (INSR) , Q13882 (PTK6) | Uniprot |
| Y377 | Phosphorylation | Uniprot | |
| K394 | Ubiquitination | Uniprot | |
| Y398 | Phosphorylation | P07949 (RET) , P06213 (INSR) | Uniprot |
| Y402 | Phosphorylation | Uniprot | |
| T406 | Phosphorylation | Uniprot | |
| Y409 | Phosphorylation | Uniprot | |
| T435 | Phosphorylation | Uniprot | |
| S439 | Phosphorylation | O14920 (IKBKB) | Uniprot |
| S443 | Phosphorylation | O14920 (IKBKB) | Uniprot |
| S446 | Phosphorylation | O14920 (IKBKB) | Uniprot |
| Y449 | Phosphorylation | Uniprot | |
| S450 | Phosphorylation | O14920 (IKBKB) | Uniprot |
| S458 | Phosphorylation | Uniprot | |
| S460 | Phosphorylation | Uniprot | |
| T470 | Phosphorylation | Uniprot | |
| T481 | Phosphorylation | Uniprot |
Research Backgrounds
DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK1 appears to be a negative regulator of the insulin signaling pathway. Modulates integrin activation by competing with talin for the same binding site on ITGB3.
Constitutively tyrosine-phosphorylated. Phosphorylated by TEC (By similarity). Phosphorylated by LYN (By similarity). Phosphorylated on tyrosine residues by the insulin receptor kinase. Results in the negative regulation of the insulin signaling pathway. Phosphorylated on tyrosine residues by SRMS.
Cytoplasm. Nucleus.
Cytoplasm>Perinuclear region.
Expressed in pancreas, heart, leukocyte and spleen. Expressed in both resting and activated peripheral blood T-cells. Expressed in breast cancer.
Interacts with ABL1 (By similarity). Interacts with RasGAP and INPP5D/SHIP1. Interacts directly with phosphorylated ITGB3. Interacts with SRMS (via the SH2 and SH3 domains).
The PTB domain mediates receptor interaction.
Belongs to the DOK family. Type A subfamily.
Research Fields
· Human Diseases > Infectious diseases: Viral > Measles.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.